Drug intelligence / Profile preview

Toca-1 shRNA

Development stage
Preclinical
Lead developer
Queen's University
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Parenteral
01

Overview

Toca-1 shRNA is a short hairpin RNA (shRNA) designed to knock down the expression of Transducer of Cdc42-dependent actin assembly-1 (Toca-1, also known as formin-binding protein 1-like or FNBP1L). Toca-1 is an adaptor protein that promotes the recruitment of actin nucleation-promoting factors to cellular membranes, facilitating cell motility and tissue invasion. Delivered via lentiviral vectors, Toca-1 shRNA has been utilized in preclinical research to investigate the role of Toca-1 in breast cancer metastasis. In vitro and in vivo studies demonstrate that Toca-1 knockdown significantly impairs EGF-induced cell migration, invasion, and extracellular matrix degradation, leading to a reduction in spontaneous lung metastasis without affecting primary tumor growth.

Other names
Toca-1 short hairpin RNAToca1 short hairpin RNAToca 1 short hairpin RNAshRNA targeting Toca-1

Beyond the preview

Go deeper on Toca-1 shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toca-1 shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call